BullFrog AI Holdings (BFRGW) Long-Term Investments (2025 - 2026)
BullFrog AI Holdings' (BFRGW) quarterly Long-Term Investments came in at $116670.0 in Q2 2026, up 100.0% on a YoY basis from $58335.0 in Q2 2025, and little changed quarter-over-quarter from $116670.0 in Q4 2025.
Powered by 
Analysis
BullFrog AI Holdings (BFRGW) Long-Term Investments (2025 - 2026) Analysis & Trends
BullFrog AI Holdings (BFRGW) has reported Long-Term Investments for 2 consecutive years, with $116670.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Long-Term Investments rose 100.0% year-over-year to $116670.0; the trailing twelve-month figure through Jun 2026 stood at $116670.0 (up 100.0% YoY), and the FY2025 full-year result was $116670.0, changed N/A from the prior year.
- Long-Term Investments held at $116670.0 in Q2 2026 per BFRGW's latest filing, from $116670.0 in the prior quarter.
- Across five years, Long-Term Investments topped out at $116670.0 in Q4 2025 and bottomed at $58335.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.04 Bn | 197.05 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 181.32 Bn | 178.14 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.20 Bn | 124.35 Bn | 2.84 Bn | 5.79 Bn |
| 4 | Regeneron Pharmaceuticals | 82.41 Bn | 74.42 Bn | 3.93 Bn | 9.83 Bn |
| 5 | Argenx Se | 61.58 Bn | 56.39 Bn | 1.37 Bn | -4.00 Mn |
| 6 | Moderna | 54.71 Bn | 49.57 Bn | 52.00 Mn | 1.77 Bn |
| 7 | Alnylam Pharmaceuticals | 34.15 Bn | 30.84 Bn | 992.69 Mn | 22.17 Mn |
| 8 | Biogen | 31.25 Bn | 29.97 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.09 Bn | 30.09 Bn | 1.16 Mn | - |
| 10 | BullFrog AI Holdings | 1.84 Mn | -5.08 Mn | 106,899.00 | 116,670.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 116,670.00 |
| Dec 31, 2025 | 116,670.00 |
| Sep 30, 2025 | 58,335.00 |
| Jun 30, 2025 | 58,335.00 |